The Influence of Low Phosphorus in Hemodialysis Patients
NCT04645459 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2020-12-04
Summary
Consuming high levels of dietary phosphate and poor adherence of phosphate-binding-therapy might induce hyperphosphatemia in the hemodialysis (HD) patients. Therefore, the risks of Chronic Kidney Disease-related Mineral and Bone Disorders (CKD-MBDs) and inflammation will be increased. This double blind and intervention randomized controlled trial study will be designed to investigate the hypothesis that if low phosphorus meals decrease serum phosphorus concentration and inflammatory indicators. A total of 80 HD patients in the HD center of Shuang Ho Hospital will be recruited and be assigned to low phosphorus meal group (LP group) and control group randomly before one-week-washout period. The subjects of LP group and control group will consume low phosphorus meals and standard meals respectively. During washout period and study period, all subjects will continue to consume their regular breakfast and take one tablet of calcium carbonate with meal. All data will be collected at baseline, one week after the washout period, and the end of the 7-days-study period. The indicators are including dietary contents, phosphate binder administration, indicators of dialysis adequacy, nutritional indicators, blood lipid indicators, biochemical indicators, CKD-MBDs indicators, and inflammation indicators. Data were analyzed by Statistical Product and Service Solutions program version 18. Paired t-test, Student's t-test, Pearson correlation coefficient and Logistic regression will be used. P \< 0.05 will be considered as statistically significant.
Conditions
- Hemodialysis Patients
Interventions
- OTHER
-
low phosphorus meals
All subjects followed their usual diets but took one tablet of calcium carbonate as phosphate binder per meal for the first week washout diet. After washout diet, subjects were assign to control or study group randomly and entered to the study period for one week. The diets of the study group were low phosphorus ( LP group), but the dietary phosphorous levels of the control group were not modified. During the study period, all subjects including LP group and control group still kept their usually accustomed behavior about regular breakfast and also took one tablet of calcium carbonate as phosphate binder with every breakfast meal. The LP group and control group replaced daily lunch and dinner with low phosphorus and standard meals respectively and should not take any phosphate binder during the study period for one week.
- OTHER
-
control meals
All subjects followed their usual diets but took one tablet of calcium carbonate as phosphate binder per meal for the first week washout diet. After washout diet, subjects were assign to control or study group randomly and entered to the study period for one week. The diets of the study group were low phosphorus ( LP group), but the dietary phosphorous levels of the control group were not modified. During the study period, all subjects including LP group and control group still kept their usually accustomed behavior about regular breakfast and also took one tablet of calcium carbonate as phosphate binder with every breakfast meal. The LP group and control group replaced daily lunch and dinner with low phosphorus and standard meals respectively and should not take any phosphate binder during the study period for one week.
Sponsors & Collaborators
-
Taipei Medical University
lead OTHER
Principal Investigators
-
Mai-Szu Wu · Taipei Medical University Shuang Ho Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-12-03
- Primary Completion
- 2021-05-28
- Completion
- 2021-05-28
Countries
- Taiwan
Study Locations
More Related Trials
-
Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis Patients
NCT07180069 ·Status: COMPLETED ·Phase: NA
-
Acute Changes in the Mineral Metabolism After a High Phosphorous Containing Meal in Dialysis Patients
NCT03868371 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis
NCT03163576 ·Status: UNKNOWN ·Phase: PHASE4
-
Dietary Phosphate and Serum Phosphorus
NCT02435017 ·Status: COMPLETED
-
Effect of Restriction of Foods Containing Phosphorus Additives
NCT01965379 ·Status: COMPLETED ·Phase: NA
-
Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease
NCT00755690 ·Status: COMPLETED ·Phase: NA
-
Study of the Influence of Dosages of 1-84 and 7-84 Fragments of Parathyroid Hormone Compared to Conventional Dosage on the Balance of Calcium and Phosphate in Hemodialysis (PTH)
NCT02859220 ·Status: COMPLETED ·Phase: NA
-
Hyperphosphatemia in Children With Chronic Kidney Disease
NCT03202407 ·Status: UNKNOWN ·Phase: PHASE3
-
Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients
NCT03861247 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients
NCT02684643 ·Status: COMPLETED ·Phase: NA
-
Effects of Dietary Phosphorus on Phosphorus and Calcium Whole-Body Balance and Kinetics in Moderate CKD
NCT06712719 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals
NCT00018135 ·Status: COMPLETED ·Phase: NA
-
Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
NCT00299572 ·Status: UNKNOWN ·Phase: PHASE4
-
Phosphorus Absorption in Healthy Adults and in Patients With Moderate Chronic Kidney Disease
NCT03108222 ·Status: UNKNOWN
-
Acute Regulation of Parathyroid Hormone by Dietary Phosphate
NCT00037193 ·Status: COMPLETED
-
Nutritional Interventions in Peritoneal Dialysis Patients with Hypoalbuminemia
NCT04546958 ·Status: COMPLETED ·Phase: NA
-
Assessing How the Body Responds to Increased Phosphate Intake, and How This Response Depends on Age and Sex.
NCT07149337 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of a Phosphate Modified Diet on Phosphate Balance and Phosphate Metabolism in Predialysis Patients Stage 3-4
NCT02073136 ·Status: COMPLETED ·Phase: NA
-
Study of 1.25 mmol/L Calcium Dialysate on Mineral Metabolism in Haemodialysis Patients.
NCT00744302 ·Status: COMPLETED ·Phase: PHASE2
-
Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease
NCT04019379 ·Status: COMPLETED ·Phase: NA
-
Serum iPTH, Calcium and Phosphate, and the Risk of Mortality in Beijing Elderly Hemodialysis Population
NCT03261154 ·Status: COMPLETED
-
Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients
NCT05577507 ·Status: COMPLETED ·Phase: PHASE4
-
Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
NCT01357317 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients
NCT00316472 ·Status: COMPLETED ·Phase: PHASE1
-
Short- and Long-Term Impact of Subtotal Parathyroidectomy on the Achievement of Bone and Mineral Parameters Recommended by Clinical Practice Guidelines in Dialysis Patients
NCT01872429 ·Status: COMPLETED